Back to Authors

Singer, Wolfgang

0000-0003-1263-6850

Mayo Clinic

Mayo Clinic

Citations 115

Submentalis Rapid Eye Movement Sleep Muscle Activity: A Potential Biomarker for Synucleinopathy
McCarter, Stuart J. , Feemster, John, Tabatabai, Grace, Sandness, David J., Timm, Paul, McCarter, Allison R., Talley, Heather N., Junna, Mithri R. , Savica, Rodolfo , Benarroch, Eduardo E. , Josephs, Keith A. , Silber, Michael H. , Louis, Erik K. St. , Feemster, John C, Tabatabai, Grace M, Timm, Paul C, St Louis, E K , McCarter, Stuart J , Singer, Wolfgang , Coon, Elizabeth A. , Boeve, Bradley F.

Annals of Neurology | October 17, 2019 | Volume: 86 | Issue: 6 | Pages: 969-974

10.1002/ana.25622 Get It

Accurate antemortem diagnosis of parkinsonism is primarily based on clinical evaluation with limited biomarkers. We evaluated the diagnostic utility of quantitative rapid eye movement (REM) sleep without atonia analysis in the submentalis and anterior tibialis muscles in parkinsonian patients (53 synucleinopathy, 24 tauopathy). Receiver operating characteristic curves determined REM sleep without atonia cutoffs distinguishing synucleinopathies from tauopathies. Elevated submentalis muscle activity was highly sensitive (70–77%) and specific (95–100%) in distinguishing synucleinopathy from tauopathy. In contrast, anterior tibialis synucleinopathy discrimination was poor. Our results suggest that elevated submentalis REM sleep without atonia appears to be a potentially useful biomarker for presumed synucleinopathy etiologies in parkinsonism. ANN NEUROL 2019;86:969–974
Refined Quantitation of Sweat Gland Innervation
Minota, Karla, Schmeichel, Ann M., Gehrking, Jade A., Mandrekar, Jay , Low, Phillip A. , Mandrekar, Jay N., Singer, Wolfgang

Journal of Neuropathology & Experimental Neurology | March 12, 2019 | Volume: 78 | Issue: 5 | Pages: 453-459

10.1093/jnen/nlz015 Get It

GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist
Chakraborty, Subhankar , Halland, Magnus , Burton, Duane D. , Desai, Anshuman, Neja, Bridget, Low, Phillip A. , Camilleri, Michael , Zinsmeister, Alan R., Bharucha, Adil E. , Chakraborty, Subhankar , Burton, Duane, Singer, Wolfgang

The Journal of Clinical Endocrinology & Metabolism | October 25, 2018 | Volume: 104 | Issue: 6 | Pages: 1967-1977

10.1210/jc.2018-01623 Get It

Multiple system atrophy and apolipoprotein E
Ogaki, Kotaro, Martens, Yuka A. , Koga, Shunsuke , Lorenzo‐Betancor, Oswaldo , Wernick, Anna I. , Walton, Ronald L., Soto, Alexandra I., Vargas, Emily , Nielsen, Henrietta M. , Fujioka, Shinsuke , Kanekiyo, Takahisa , Uitti, Ryan J. , Gerpen, Jay A. van, Cheshire, William P. , Low, Phillip A. , Bu, Guojun , Ross, Owen A. , Koga, Shunsuke , Labbé, Catherine, Lorenzo-Betancor, Oswaldo, Vargas, Emily R, Van Gerpen, Jay A, Wszolek, Z.K. , Cheshire, William P , Ross, Owen A , Bu, Guojun , Heckman, Michael G. , Labbé, Catherine , Wszołek, Zbigniew K. , Singer, Wolfgang , Dickson, Dennis W.

Movement Disorders | February 14, 2018 | Volume: 33 | Issue: 4 | Pages: 647-650

10.1002/mds.27297 Get It

ABSTRACTBackground: Dysregulation of the specialized lipid metabolism involved in myelin synthesis and maintenance by oligodendrocytes has been associated with the unique neuropathology of MSA. We hypothesized that apolipoprotein E, which is associated with neurodegeneration, may also play a role in the pathogenesis of MSA.Objective: This study evaluated genetic associations of Apolipoprotein E alleles with risk of MSA and α‐synuclein pathology, and also examined whether apolipoprotein E isoforms differentially affect α‐synuclein uptake in a oligodendrocyte cell.Methods: One hundred sixty‐eight pathologically confirmed MSA patients, 89 clinically diagnosed MSA patients, and 1,277 control subjects were genotyped for Apolipoprotein E. Human oligodendrocyte cell lines were incubated with α‐synuclein and recombinant human apolipoprotein E, with internalized α‐synuclein imaged by confocal microscopy and cells analyzed by flow cytometry.Results: No significant association with risk of MSA or was observed for either Apolipoprotein E ɛ2 or ɛ4. α‐Synuclein burden was also not associated with Apolipoprotein E alleles in the pathologically confirmed patients. Interestingly, in our cell assays, apolipoprotein E ɛ4 significantly reduced α‐synuclein uptake in the oligodendrocytic cell line.Conclusions: Despite differential effects of apolipoprotein E isoforms on α‐synuclein uptake in a human oligodendrocytic cell, we did not observe a significant association at the Apolipoprotein E locus with risk of MSA or α‐synuclein pathology. © 2018 International Parkinson and Movement Disorder Society
Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies
Norcliffe‐Kaufmann, Lucy , Kaufmann, Horacio , Palma, Jose‐Alberto , Shibao, Cyndya A. , Low, Phillip A. , Robertson, David, Kaufmann, Horacio , Palma, Jose-Alberto , Shibao, Cyndya A , Biaggioni, Italo , Peltier, Amanda , Singer, Wolfgang , Goldstein, David S. , Gibbons, Christopher H. , Freeman, Roy L.

Annals of Neurology | February 5, 2018 | Volume: 83 | Issue: 3 | Pages: 522-531

10.1002/ana.25170 Get It

Objective Blunted tachycardia during hypotension is a characteristic feature of patients with autonomic failure, but the range has not been defined. This study reports the range of orthostatic heart rate (HR) changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Methods Patients evaluated at sites of the U.S. Autonomic Consortium (NCT01799915) underwent standardized autonomic function tests and full neurological evaluation. Results We identified 402 patients with orthostatic hypotension (OH) who had normal sinus rhythm. Of these, 378 had impaired sympathetic activation (ie, neurogenic OH) and based on their neurological examination were diagnosed with Parkinson disease, dementia with Lewy bodies, pure autonomic failure, or multiple system atrophy. The remaining 24 patients had preserved sympathetic activation and their OH was classified as nonneurogenic, due to volume depletion, anemia, or polypharmacy. Patients with neurogenic OH had twice the fall in systolic blood pressure (SBP; −44 ± 25 vs −21 ± 14 mmHg [mean ± standard deviation], p < 0.0001) but only one‐third of the increase in HR of those with nonneurogenic OH (8 ± 8 vs 25 ± 11 beats per minute [bpm], p < 0.0001). A ΔHR/ΔSBP ratio of 0.492 bpm/mmHg had excellent sensitivity (91.3%) and specificity (88.4%) to distinguish between patients with neurogenic from nonneurogenic OH (area under the curve = 0.96, p < 0.0001). Within patients with neurogenic OH, HR increased more in those with multiple system atrophy ( p = 0.0003), but there was considerable overlap with patients with Lewy body disorders. Interpretation A blunted HR increase during hypotension suggests a neurogenic cause. A ΔHR/ΔSBP ratio < 0.5 bpm/mmHg is diagnostic of neurogenic OH. Ann Neurol 2018;83:522–531
Pediatric Disorders of Orthostatic Intolerance
Stewart, Julian M. , Boris, Jeffrey R. , Chelimsky, Gisela , Fischer, Phillip R., Fortunato, John E. , Jarjour, Imad T. , Medow, Marvin S. , Numan, Mohammed T. , Tarbell, Sally E. , Chelimsky, Thomas , Society, The Pediatric Writing Group of the American Autonomic, Pianosi, Paolo T. , Grubb, Blair P. , Heyer, Geoffrey L. , Singer, Wolfgang , Society, The Pediatric Writing Group of the American Autonomic

Pediatrics | December 8, 2017 | Volume: 141 | Issue: 1 | Pages: No page available

10.1542/peds.2017-1673 Get It

Orthostatic intolerance (OI), having difficulty tolerating an upright posture because of symptoms or signs that abate when returned to supine, is common in pediatrics. For example, ∼40% of people faint during their lives, half of whom faint during adolescence, and the peak age for first faint is 15 years. Because of this, we describe the most common forms of OI in pediatrics and distinguish between chronic and acute OI. These common forms of OI include initial orthostatic hypotension (which is a frequently seen benign condition in youngsters), true orthostatic hypotension (both neurogenic and nonneurogenic), vasovagal syncope, and postural tachycardia syndrome. We also describe the influences of chronic bed rest and rapid weight loss as aggravating factors and causes of OI. Presenting signs and symptoms are discussed as well as patient evaluation and testing modalities. Putative causes of OI, such as gravitational and exercise deconditioning, immune-mediated disease, mast cell activation, and central hypovolemia, are described as well as frequent comorbidities, such as joint hypermobility, anxiety, and gastrointestinal issues. The medical management of OI is considered, which includes both nonpharmacologic and pharmacologic approaches. Finally, we discuss the prognosis and long-term implications of OI and indicate future directions for research and patient management.